138 related articles for article (PubMed ID: 21854745)
1. Protein signatures for classification and prognosis of gastric cancer a signaling pathway-based approach.
Wang D; Ye F; Sun Y; Li W; Liu H; Jiang J; Zhang Y; Liu C; Tong W; Gao L; Sun Y; Zhang W; Seetoe T; Lee P; Suo J; Zhang DY
Am J Pathol; 2011 Oct; 179(4):1657-66. PubMed ID: 21854745
[TBL] [Abstract][Full Text] [Related]
2. Protein predictive signatures for lymph node metastasis of gastric cancer.
Li W; Ye F; Wang D; Sun X; Tong W; Lian G; Jiang J; Suo J; Zhang DY
Int J Cancer; 2013 Apr; 132(8):1851-9. PubMed ID: 23011604
[TBL] [Abstract][Full Text] [Related]
3. Protein expression profiling and molecular classification of gastric cancer by the tissue array method.
Lee HS; Cho SB; Lee HE; Kim MA; Kim JH; Park DJ; Kim JH; Yang HK; Lee BL; Kim WH
Clin Cancer Res; 2007 Jul; 13(14):4154-63. PubMed ID: 17634543
[TBL] [Abstract][Full Text] [Related]
4. Protein profiling of Helicobacter pylori-associated gastric cancer.
Lian G; Wei C; Wang D; Cui M; Wang Z; Liu X; Li W; Wang L; Wang Q; Zhang DY; Suo J; Ye F
Am J Pathol; 2014 May; 184(5):1343-54. PubMed ID: 24589339
[TBL] [Abstract][Full Text] [Related]
5. Efficient isolation and proteomic analysis of cell plasma membrane proteins in gastric cancer reveal a novel differentiation and progression related cell surface marker, R-cadherin.
Chen B; Luo QC; Chen JB; Lin LE; Luo MX; Ren HY; Chen PQ; Shi LG
Tumour Biol; 2016 Sep; 37(9):11775-11787. PubMed ID: 27029387
[TBL] [Abstract][Full Text] [Related]
6. Expression of eukaryotic translation initiation factor 5A-2 (eIF5A-2) associated with poor survival in gastric cancer.
Yang Q; Ye Z; Zhang Q; Zhao Z; Yuan H
Tumour Biol; 2016 Jan; 37(1):1189-95. PubMed ID: 26282002
[TBL] [Abstract][Full Text] [Related]
7. The screening and analysis of protein signatures and signaling associated with chemoresistance based on Protein Pathway Array technology in gastric cancer.
Lian G; Li L; Ye F; Wang D; Liu J; Shi Y; Jing C; Suo J; Zhang DY; Chen M
Oncol Rep; 2018 Jan; 39(1):307-315. PubMed ID: 29115543
[TBL] [Abstract][Full Text] [Related]
8. Clinicopathological significance of orphan nuclear receptor Nurr1 expression in gastric cancer.
Guo J; Zu G; Zhou T; Xing J; Wang Z
Clin Transl Oncol; 2015 Oct; 17(10):788-94. PubMed ID: 26022133
[TBL] [Abstract][Full Text] [Related]
9. Comparative proteomic analysis of human malignant ascitic fluids for the development of gastric cancer biomarkers.
Jin J; Son M; Kim H; Kim H; Kong SH; Kim HK; Kim Y; Han D
Clin Biochem; 2018 Jun; 56():55-61. PubMed ID: 29654727
[TBL] [Abstract][Full Text] [Related]
10. Serum proteome profiling reveals SOX3 as a candidate prognostic marker for gastric cancer.
Shen J; Zhai J; Wu X; Xie G; Shen L
J Cell Mol Med; 2020 Jun; 24(12):6750-6761. PubMed ID: 32363730
[TBL] [Abstract][Full Text] [Related]
11. Overexpression of HOXA10 promotes gastric cancer cells proliferation and HOXA10(+)/CD44(+) is potential prognostic biomarker for gastric cancer.
Han Y; Lu S; Wen YG; Yu FD; Zhu XW; Qiu GQ; Tang HM; Peng ZH; Zhou CZ
Eur J Cell Biol; 2015 Dec; 94(12):642-52. PubMed ID: 26552644
[TBL] [Abstract][Full Text] [Related]
12. [Prognostic factors of lymph node-negative metastasis gastric cancer].
Sun D; Xu H; Huang J
Zhonghua Wei Chang Wai Ke Za Zhi; 2017 Feb; 20(2):190-194. PubMed ID: 28226354
[TBL] [Abstract][Full Text] [Related]
13. Clinical significance of TM4SF1 as a tumor suppressor gene in gastric cancer.
Peng XC; Zeng Z; Huang YN; Deng YC; Fu GH
Cancer Med; 2018 Jun; 7(6):2592-2600. PubMed ID: 29665316
[TBL] [Abstract][Full Text] [Related]
14. The effectiveness of the new (7th) UICC N classification in the prognosis evaluation of gastric cancer patients: a comparative study between the 5th/6th and 7th UICC N classification.
Chae S; Lee A; Lee JH
Gastric Cancer; 2011 Jun; 14(2):166-71. PubMed ID: 21360132
[TBL] [Abstract][Full Text] [Related]
15. A novel proteomics-based clinical diagnostics technology identifies heterogeneity in activated signaling pathways in gastric cancers.
Lee J; Kim S; Kim P; Liu X; Lee T; Kim KM; Do IG; Park JO; Park SH; Jang J; Hoe N; Harvie G; Kuller A; Jain A; Meyer G; Leesman G; Park YS; Choi MG; Sohn TS; Bae JM; Lim HY; Singh S; Kang WK
PLoS One; 2013; 8(1):e54644. PubMed ID: 23372746
[TBL] [Abstract][Full Text] [Related]
16. Lymph node ratio is an independent prognostic factor in gastric cancer after curative resection (R0) regardless of the examined number of lymph nodes.
Alatengbaolide ; Lin D; Li Y; Xu H; Chen J; Wang B; Liu C; Lu P
Am J Clin Oncol; 2013 Aug; 36(4):325-30. PubMed ID: 22547011
[TBL] [Abstract][Full Text] [Related]
17. GAGE7B promotes tumor metastasis and growth via activating the p38δ/pMAPKAPK2/pHSP27 pathway in gastric cancer.
Shi DB; Ma RR; Zhang H; Hou F; Guo XY; Gao P
J Exp Clin Cancer Res; 2019 Mar; 38(1):124. PubMed ID: 30871606
[TBL] [Abstract][Full Text] [Related]
18. Identification of prognosis-related proteins in advanced gastric cancer by mass spectrometry-based comparative proteomics.
Jia SQ; Niu ZJ; Zhang LH; Zhong XY; Shi T; Du H; Zhang GG; Hu Y; Su XL; Ji JF
J Cancer Res Clin Oncol; 2009 Mar; 135(3):403-11. PubMed ID: 18830628
[TBL] [Abstract][Full Text] [Related]
19. Elevated spondin-2 expression correlates with progression and prognosis in gastric cancer.
Jin C; Lin JR; Ma L; Song Y; Shi YX; Jiang P; Dong Y; Li XS
Oncotarget; 2017 Feb; 8(6):10416-10424. PubMed ID: 28060752
[TBL] [Abstract][Full Text] [Related]
20. GPRC5A overexpression predicted advanced biological behaviors and poor prognosis in patients with gastric cancer.
Liu H; Zhang Y; Hao X; Kong F; Li X; Yu J; Jia Y
Tumour Biol; 2016 Jan; 37(1):503-10. PubMed ID: 26227221
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
